a multi-institutional randomized clinical trial was carried out to evaluate the effect of vincristine ( v ) added to cyclophosphamide , methotrexate , 5-fluorouracil , and prednisone ( cmfp ) for the treatment of metastatic breast cancer .
C0025677
methotrexate
C0055985
cmfp